Masterclass in Spinal Cord Injury and Neural Tube Defects is organized by MKH Events Middle East and will be held during Apr 13 - 14, 2018 at Abu Dhabi National Exhibition Centre, Abu Dhabi, United Arab Emirates.
The target audience for this medical event is Physical Medicine and Rehabilitation Physicians, Neurologists and Neurosurgeons, Urologists, Neurourologists, Pediatricians and Pediatric Surgeons, Gynecologists, Urogynecologists, Psychologists, Andrologists, Nurses and Urotherapists.
Course Description:
The "Masterclass on the Management of Bladder, Bowel in Spinal Cord Injury and Neural Tube Defects” was created with the aims of “Reducing the Gap” of knowledge and standardizing the management of the affected Patients at a Global level, and in particular in Emerging, (Developing), Countries.
The 1st Masterclass (Italy - 2017) aimed at including an structures scientific program of theoretical lessons and case studies, held by International Experts, who have been dedicating their career to the vast multidisciplinary field of serious spinal lesions and conditions.The target audience of the 2nd Masterclass are doctors, nurses, physiotherapists, occupational therapists and psychologists with a specific interest.
We are advertising the Event globally, but we are trying to recruit the highest number of Delegates from developing Countries or Countries in need of standardized recommendations for clinical management, (China, India, United Arab Emirates, Portugal, Spain, Latin America, etc.).
This will be a highly interactive able to give some practical "take home messages" which will standardize and modernize practice for all attending Healthcare Providers.
Learning Objectives :
• Arrange an ideal situation for an exchange of ideas on Spinal Cord Injury and Neural Tube Defects.
• Discuss clinical and scientific information about Spinal Cord Injury and Neural Tube Defects.
• Adapt to expand and support the international network, with the aim of establishing the essential recommendations and later on guidelines, to improve survival, QoL,outcomes, clinical management, homeware and self-management of patients.
Additional details will be posted as soon as they are available.